Recent in vitro and in vivo studies have contributed to elucidating the role of adiponectin in the growth and progression of ER-positive breast cancer, identifying this adipokine as a tumor-promoting growth factor [28,29,30,37,38,39,40]. This evidence concerns the gene ADIPOQ and neoplasm.